[A Response] to the Citron Research Report on Nanox

Citron Research releases a report calling Nanox worth $0 causing the stock to tumble. Nanox reached as high as nearly $67 a share in a matter of weeks to dramatically dropping towards $28. Citron research claimed Nanox a farce, Theranos 2.0, and put a price target at $0. After, Nanox had IPO’d at $18 a share, and a $20.34 open, it has essentially became an IPO darling. Nanox claims they believe the Citron report is false and misleading.